Hutch News

Hutch News

Stories tagged 'Vaccine development - Viral cancers'

Meet Global Oncology's deputy program head

Key early experiences shaped Dr. Thomas Uldrick's path toward HIV-associated cancers, global health

Feb. 22, 2018 | By Mary Engel / Fred Hutch News Service

Dr. Thomas Uldrick brings expertise in HIV-related cancers and experience in — and a passion for — developing clinical trials to his new position at Fred Hutch Global Oncology.

View story >


Science to watch in 2018: From immunotherapy to gene therapy, big data to new tech

Fred Hutch experts lend their predictions for the coming year’s advances

Jan. 12, 2018 | By Rachel Tompa / Fred Hutch News Service

We asked Fred Hutch researchers for their predictions on scientific advances to watch in the coming year. Look for their tips on what's next in cancer immunotherapy, precision oncology, gene editing, infectious disease research, cancer prevention and more.

View story >


10 highlights of Fred Hutch science in 2017

A look back at notable discoveries in cancer immunotherapy, HIV prevention and more

Dec. 28, 2017 | by Sabin Russell and Susan Keown / Fred Hutch News Service

It's been a year of breakthroughs at Fred Hutch. Here are 10 of our favorites.

View story >


Enlisting the microbiome in the quest for an AIDS vaccine

We now know that microbial communities, especially in our guts, profoundly affect immune response

Nov. 22, 2017 | By Sabin Russell / Fred Hutch News Service

Scientists at Fred Hutch are studying how the microbiome alters the immune system’s response to vaccines. Their work is already providing new insights on interactions between microbes in the body and the immune system that have implications for improving many types of vaccines.

View story >


Science without borders

At Fred Hutch and other U.S. research centers, a global village works to cure cancer and other diseases

Oct. 16, 2017 | By Mary Engel / Fred Hutch Research Center

Fred Hutch, like other major U.S. cancer research centers, attracts top scientists from around the world working to cure cancer, HIV and other diseases

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 7, 2017

A common, normally dormant virus called cytomegalovirus can make matters worse for patients with critical illness — and a new study by Fred Hutch's Dr. Michael Boeckh and colleagues at the University of Washington hints that preventing the virus from reawakening in these critical moments could stem some of its harm.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.